2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products

Code: 
2100

Selected funding rounds

Date Company Profile Round Ccy Amount
Apr 2012 Tioga Pharmaceuticals Inc Series B
Apr 2012 Tioga Pharmaceuticals Inc Series B
Apr 2012 ALDEA Pharmaceuticals N/A
22 Mar 2012 BioRelix Inc Advanced fight against drug resistant microbes by attacking novel targets with novel drugs. N/A USD 2,560,000
15 Mar 2012 Kala Pharmaceuticals Inc Developer of products that penetrate the mucosal barrier to treat a variety of severe diseases Venture
13 Feb 2012 Bind Biosciences Inc Developer of “smart” therapeutic targeted nano-particles capable of differential delivery and controlled drug release to diseased tissue Series D
Feb 2012 Tranzyme Pharma Drug discovery and development, focused on gastroenterology indications Debt
Feb 2012 Ceptaris Therapeutics Inc Specialty pharmaceuticals company. Debt
Feb 2012 Cervilenz Inc Series A
Feb 2012 Collegium Pharmaceutical Inc Collegium Pharmaceutical, Inc., is a privately held pharmaceutical company. N/A
Feb 2012 Auxogyn Inc Series A
Feb 2012 Collegium Pharmaceutical Inc Collegium Pharmaceutical, Inc., is a privately held pharmaceutical company. N/A
Jan 2012 Roka Bioscience Inc Series D
Jan 2012 Probiodrug Biopharmaceutical company focused on the development of innovative small molecule drugs. Venture
Jan 2012 PowerVision Inc Series C
Jan 2012 Probiodrug Biopharmaceutical company focused on the development of innovative small molecule drugs. Venture
Jan 2012 Juventas Therapeutics Inc Series B
Jan 2012 Probiodrug Biopharmaceutical company focused on the development of innovative small molecule drugs. Venture
Jan 2012 Juventas Therapeutics Inc Series B
Jan 2012 AssureRx Health Inc Personalized medicine company specializing in pharmacogenetics Debt

Pages

Selected companies

Company type: 
Small molecule drug discovery and development company.
Company type: 
DNA testing and genome sequencing firm.
Company type: 
Developer of medicines for treating skin diseases caused by resistant microbes.
Company type: 
Provider of customer services and compliant packaging solutions for the legal cannabis industry; both medical and recreational markets.
Company type: 
Discoverer and developer of small molecule drugs for osteoarthritis/ inflammation and type II diabetes.
Company type: 
Drug discovery company committed to the development of breakthrough medicines for the treatment of cancer.
Subscribe to RSS - 2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products